(0.15%) 5 214.50 points
(0.16%) 39 059 points
(-0.01%) 18 193 points
(-0.32%) $78.23
(-0.27%) $2.19
(0.04%) $2 332.10
(0.17%) $27.66
(1.92%) $983.45
(-0.06%) $0.928
(0.32%) $10.86
(0.05%) $0.796
(-0.82%) $90.60
-10.53% $ 0.0102
Live Chart Being Loaded With Signals
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 188 055 |
Średni wolumen | 229 343 |
Kapitalizacja rynkowa | 317 336 |
EPS | $0 ( 2024-04-14 ) |
Następna data zysków | ( $0 ) 2024-07-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0.0100 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2014-07-25 | Cannabics Inc. | Buy | 18 239 594 | COMMON STOCK |
2014-06-23 | Cannabics Inc. | Buy | 14 525 000 | Common Stock |
2014-05-08 | Cannabics Inc. | Buy | 20 500 000 | Common Stock |
2014-05-08 | Mills Thomas E | Sell | 20 500 000 | common stock |
2014-04-25 | Mills Thomas E | Buy | 20 500 000 | common stock |
INSIDER POWER |
---|
0.00 |
Last 15 transactions |
Buy: 135 764 594 | Sell: 73 500 000 |
Cannabics Pharmaceuticals Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cannabics Pharmaceuticals Finanse
Annual | 2023 |
Przychody: | $410 165 |
Zysk brutto: | $248 104 (60.49 %) |
EPS: | $-0.420 |
FY | 2023 |
Przychody: | $410 165 |
Zysk brutto: | $248 104 (60.49 %) |
EPS: | $-0.420 |
FY | 2022 |
Przychody: | $29 958.00 |
Zysk brutto: | $-168 569 (-562.68 %) |
EPS: | $-3.08 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.0200 |
Financial Reports:
No articles found.
Cannabics Pharmaceuticals
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it develops Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids for the treatment of cancer anorexia-cachexia syndrome; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. CNBX Pharmaceuticals Inc. is a subsidiary of Cannabics Inc.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej